The Patent Pathology (TPP)

Capture d’écran 2014-10-18 à 18.13.18


Wikileaks renders public health a vital service and releases UPDATED SECRET TRANS PACIFIC PARTNERSHIP AGREEMENT (TPP) – IP CHAPTER (2nd Publication), an economic agreement secretly in the making which would have terrible implications on access to medicine if adopted. 

“Thursday 16 October 2014, WikiLeaks released a second updated version of the Trans-Pacific Partnership (TPP) Intellectual Property Rights Chapter. The TPP is the world’s largest economic trade agreement that will, if it comes into force, encompass more than 40 per cent of the world’s GDP. The IP Chapter covers topics from pharmaceuticals, patent registrations and copyright issues to digital rights. Experts say it will affect freedom of information, civil liberties and access to medicines globally. The WikiLeaks release comes ahead of a Chief Negotiators’ meeting in Canberra on 19 October 2014, which is followed by what is meant to be a decisive Ministerial meeting in Sydney on 25–27 October.

Despite the wide-ranging effects on the global population, the TPP is currently being negotiated in total secrecy by 12 countries. Few people, even within the negotiating countries’ governments, have access to the full text of the draft agreement and the public, who it will affect most, none at all. Large corporations, however, are able to see portions of the text, generating a powerful lobby to effect changes on behalf of these groups and bringing developing country members reduced force, while the public at large gets no say. Read the full press release here. ”

See also Julian Assange and Sarah Harrison’ editorial : 


“Despite claims from the Trans-Pacific Partnership (TPP) states that a final agreement would be reached by the start of this year, the publication of the draft IP Chapter led to a backlash – no agreement was realised, country alignments have altered and negotiations continue. However, US negotiators have made a counter-attack. The latest leaked version of the draft text shows the United States pushing for measures that would significantly constrain affordable access to vital generic drugs, such as cancer drugs and treatments for communicable diseases such as Ebola. Continue reading here

And also PUBLIC CITIZEN Analyses of the newly leaked IP chapter